These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. A decade from discovery to therapy: Lingo-1, the dark horse in neurological and psychiatric disorders. Andrews JL; Fernandez-Enright F Neurosci Biobehav Rev; 2015 Sep; 56():97-114. PubMed ID: 26143511 [TBL] [Abstract][Full Text] [Related]
10. Tyrosine hydroxylase from cloning to neuropsychiatric disorders. Mallet J Brain Res Bull; 1999; 50(5-6):381-2. PubMed ID: 10643445 [No Abstract] [Full Text] [Related]
12. Gene-environment interactions informing therapeutic approaches to cognitive and affective disorders. Rogers J; Renoir T; Hannan AJ Neuropharmacology; 2019 Feb; 145(Pt A):37-48. PubMed ID: 29277490 [TBL] [Abstract][Full Text] [Related]
13. [Physical training for neurological and mental diseases]. Henkel K; Reimers CD; Knapp G; Schneider F Nervenarzt; 2014 Dec; 85(12):1521-8. PubMed ID: 25380564 [TBL] [Abstract][Full Text] [Related]
14. Role of Splice Variants of Gtf2i, a Transcription Factor Localizing at Postsynaptic Sites, and Its Relation to Neuropsychiatric Diseases. Shirai Y; Li W; Suzuki T Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212274 [TBL] [Abstract][Full Text] [Related]
15. [Immaturity of brain as an endophenotype of neuropsychiatric disorders]. Hagihara H; Shoji H; Miyakawa T Nihon Yakurigaku Zasshi; 2016; 148(4):168-175. PubMed ID: 27725563 [No Abstract] [Full Text] [Related]
16. Collaboration in translational neuroscience: a call to arms. Ivinson AJ Neuron; 2014 Nov; 84(3):521-5. PubMed ID: 25442928 [TBL] [Abstract][Full Text] [Related]
18. [Advances in neuroscience and therapeutic research on neurological diseases--the present status and future prospects (discussion)]. Tsuji S; Isa T; Kato T; Mizusawa H; Takahashi T; Kato Y; Todo T; Okabe S Brain Nerve; 2007 Jan; 59(1):6-22. PubMed ID: 17354374 [No Abstract] [Full Text] [Related]